View in EDS

Pembrolizumab plus lenvatinib as second-line treatment in patients with pleural mesothelioma (PEMMELA): cohort 2 of a single-arm, phase 2 study.

Saved in:
Bibliographic Details
Title: Pembrolizumab plus lenvatinib as second-line treatment in patients with pleural mesothelioma (PEMMELA): cohort 2 of a single-arm, phase 2 study.
Authors: Douma, Li-Anne H1 (AUTHOR), van der Noort, Vincent2 (AUTHOR), Lalezari, Ferry3 (AUTHOR), de Vries, Jeltje F2 (AUTHOR), Monkhorst, Kim4 (AUTHOR), Smesseim, Illaa1 (AUTHOR), Baas, Paul1 (AUTHOR), Schilder, Bodien1 (AUTHOR), Vermeulen, Marrit2 (AUTHOR), Burgers, Jacobus A1 (AUTHOR) s.burgers@nki.nl, de Gooijer, Cornedine J1 (AUTHOR)
Source: Lancet Oncology. Dec2025, Vol. 26 Issue 12, p1676-1684. 9p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 189717302
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Pembrolizumab plus lenvatinib as second-line treatment in patients with pleural mesothelioma (PEMMELA): cohort 2 of a single-arm, phase 2 study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Douma%2C+Li-Anne+H%22">Douma, Li-Anne H</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22van+der+Noort%2C+Vincent%22">van der Noort, Vincent</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lalezari%2C+Ferry%22">Lalezari, Ferry</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22de+Vries%2C+Jeltje+F%22">de Vries, Jeltje F</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Monkhorst%2C+Kim%22">Monkhorst, Kim</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Smesseim%2C+Illaa%22">Smesseim, Illaa</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Baas%2C+Paul%22">Baas, Paul</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Schilder%2C+Bodien%22">Schilder, Bodien</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Vermeulen%2C+Marrit%22">Vermeulen, Marrit</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Burgers%2C+Jacobus+A%22">Burgers, Jacobus A</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> s.burgers@nki.nl</i><br /><searchLink fieldCode="AR" term="%22de+Gooijer%2C+Cornedine+J%22">de Gooijer, Cornedine J</searchLink><relatesTo>1</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Lancet+Oncology%22">Lancet Oncology</searchLink>. Dec2025, Vol. 26 Issue 12, p1676-1684. 9p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=189717302
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/S1470-2045(25)00514-5
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 9
        StartPage: 1676
    Titles:
      – TitleFull: Pembrolizumab plus lenvatinib as second-line treatment in patients with pleural mesothelioma (PEMMELA): cohort 2 of a single-arm, phase 2 study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Douma, Li-Anne H
      – PersonEntity:
          Name:
            NameFull: van der Noort, Vincent
      – PersonEntity:
          Name:
            NameFull: Lalezari, Ferry
      – PersonEntity:
          Name:
            NameFull: de Vries, Jeltje F
      – PersonEntity:
          Name:
            NameFull: Monkhorst, Kim
      – PersonEntity:
          Name:
            NameFull: Smesseim, Illaa
      – PersonEntity:
          Name:
            NameFull: Baas, Paul
      – PersonEntity:
          Name:
            NameFull: Schilder, Bodien
      – PersonEntity:
          Name:
            NameFull: Vermeulen, Marrit
      – PersonEntity:
          Name:
            NameFull: Burgers, Jacobus A
      – PersonEntity:
          Name:
            NameFull: de Gooijer, Cornedine J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: Dec2025
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 14702045
          Numbering:
            – Type: volume
              Value: 26
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: Lancet Oncology
              Type: main
ResultId 1